Details of the Drug Reposition

General Information of This Drug (ID: DMVTHER)

Drug Name
Lincomycin   DMVTHER
Synonyms
Cillimycin; Epilincomycin; Jiemycin; LCM; Lincocin; Lincocine; Lincolcina; Lincolnensin; Lincomicina; Lincomix; Lincomycine; Lincomycinum; Lincomyocin; Lincorex; Mycivin; Lincomycin A; Lincomycine [French]; CBMicro_021584; Lincomix 20; Pura Ject 100; Lincocin (TN); Lincomicina [INN-Spanish]; Lincomycine [INN-French]; Lincomycinum [INN-Latin]; U 10,149A; Lincomycin (USAN/INN); Lincomycin [USAN:INN:BAN]; Lincomycin, (2S-cis)-Isomer; Methyl 6,8-dideoxy-6-[(1-methyl-4-propylprolyl)amino]-1-thiooctopyranoside
Therapeutic Class
Antibiotics
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Streptococcus infection DIS04U9T 1B53 Approved [1]
Pneumococcal infection DIS6SXQD CA00-CA40 Approved [1]
------------------------------------------------------------------------------------
1 Withdrawn Indication(s)
Indication Name Indication ID ICD-11 Status REF
Gram-positive bacterial infection DISZ44JH 1B74-1G40 Withdrawn [2]
------------------------------------------------------------------------------------

References

1 Lincomycin FDA Label
2 A Study of Cidofovir in HIV-Infected Children With Cytomegalovirus (CMV) Disease